We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$8.72B
AUM Growth
+$530M
Cap. Flow
+$148M
Cap. Flow %
1.7%
Top 10 Hldgs %
28.95%
Holding
403
New
16
Increased
188
Reduced
143
Closed
14

Top Buys

Rank Stock Value
1
ENB icon
Enbridge
ENB
+$84.7M
2
XOM icon
ExxonMobil
XOM
+$52.3M
3
ADI icon
Analog Devices
ADI
+$51.3M
4
KMB icon
Kimberly-Clark
KMB
+$48.2M
5
SJM icon
J.M. Smucker
SJM
+$48.2M

Top Sells

Rank Stock Value
1
SE
Spectra Energy Corp Wi
SE
+$147M
2
TGT icon
Target
TGT
+$54.3M
3
KO icon
Coca-Cola
KO
+$52.1M
4
TXN icon
Texas Instruments
TXN
+$46M
5
ABT icon
Abbott
ABT
+$42.1M

Sector Composition

Rank Sector Weight
1 Technology 16.91%
2 Healthcare 15.12%
3 Consumer Staples 14.29%
4 Financials 13.81%
5 Industrials 12.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OEC icon
226
Orion
OEC
$385M
$1.21M 0.01%
59,160
+1,340
+2% +$27.5K
MLAB icon
227
Mesa Laboratories
MLAB
$584M
$1.21M 0.01%
9,835
+1,050
+12% +$129K
JJSF icon
228
J&J Snack Foods
JJSF
$1.48B
$1.2M 0.01%
8,865
-4,420
-33% -$583K
BF.B icon
229
Brown-Forman Class B
BF.B
$12.8B
$1.2M 0.01%
40,513
-110
-0.3% -$3.27K
LMAT icon
230
LeMaitre Vascular
LMAT
$2.37B
$1.2M 0.01%
48,585
+5,320
+12% +$125K
USPH icon
231
US Physical Therapy
USPH
$1.18B
$1.18M 0.01%
18,100
+6,885
+61% +$488K
CVS icon
232
CVS Health
CVS
$134B
$1.17M 0.01%
14,922
+167
+1% +$13.3K
MDY icon
233
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.7B
$1.17M 0.01%
3,744
-70
-2% -$21.7K
MATW icon
234
Matthews International
MATW
$876M
$1.15M 0.01%
17,048
+1,815
+12% +$126K
REIS
235
DELISTED
Reis, Inc.
REIS
$1.15M 0.01%
63,966
+3,905
+7% +$76K
ZTS icon
236
Zoetis
ZTS
$32.3B
$1.14M 0.01%
21,297
-407
-2% -$22K
TRV icon
237
Travelers Companies
TRV
$78B
$1.13M 0.01%
9,400
-123
-1% -$14.8K
SEMG
238
DELISTED
SEMGROUP CORPORATION
SEMG
$1.13M 0.01%
31,320
+1,795
+6% +$68.3K
DOX icon
239
Amdocs
DOX
$5.88B
$1.13M 0.01%
18,452
+4,094
+29% +$246K
YUM icon
240
Yum! Brands
YUM
$40.6B
$1.12M 0.01%
17,577
CHE icon
241
Chemed
CHE
$7.07B
$1.11M 0.01%
6,088
-98
-2% -$17.1K
TYPE
242
DELISTED
Monotype Imaging Holdings Inc.
TYPE
$1.1M 0.01%
54,860
+22,155
+68% +$463K
IEFA icon
243
iShares Core MSCI EAFE ETF
IEFA
$191B
$1.1M 0.01%
18,931
+136
+0.7% +$7.64K
MEDP icon
244
Medpace
MEDP
$16B
$1.05M 0.01%
+35,300
New +$1.14M
FLIR
245
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
$1.05M 0.01%
28,897
-3,170
-10% -$114K
VOD icon
246
Vodafone
VOD
$36.1B
$1.04M 0.01%
39,341
+459
+1% +$11.8K
IWR icon
247
iShares Russell Mid-Cap ETF
IWR
$56.3B
$1.03M 0.01%
22,076
+308
+1% +$14.3K
NSC icon
248
Norfolk Southern
NSC
$75.6B
$1.01M 0.01%
9,063
-940
-9% -$110K
NS
249
DELISTED
NuStar Energy L.P.
NS
$1.01M 0.01%
19,516
-107
-0.5% -$5.63K
ATO icon
250
Atmos Energy
ATO
$28.9B
$1M 0.01%
12,670
+325
+3% +$24.9K

Similar funds

Bahl & Gaynor's Q1 2017 Portfolio in Review

As of Q1 2017, Bahl & Gaynor held 403 positions worth $8.72B, up 6.5% from $8.19B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Bahl & Gaynor's Q1 2017 filing shows 16 new, 188 increased, 143 reduced and 14 closed positions. Its largest new stake was California Resources Corporation: 63,538 shares worth $956K. The largest sale was Spectra Energy Corp Wi, an estimated $147M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Bahl & Gaynor's largest Q1 2017 buy was California Resources Corporation: 63,538 shares worth $956K.
  • Bahl & Gaynor added most to Enbridge in Q1 2017, an estimated $84.7M increase.
  • Bahl & Gaynor's biggest Q1 2017 reduction was Target, cutting an estimated $54.3M.
  • Bahl & Gaynor fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $147M.
  • Bahl & Gaynor's ten largest holdings make up 29% of its $8.72B portfolio in Q1 2017.
  • Bahl & Gaynor opened 16 new positions and closed 14 in Q1 2017.
  • Bahl & Gaynor's portfolio value rose 6.5% quarter-over-quarter to $8.72B.

Based on Bahl & Gaynor's 13F filing for Q1 2017, filed 9 May 2017.